Nutritional Status of Patients Victims of Haemorragic Accidents With Antivitamins K
2 other identifiers
observational
300
1 country
1
Brief Summary
Bleeding under vitamin K antagonists are a major iatrogenic causes of hospitalization, subject to a fatal outcome in more than one third of cases, mortality is particularly high in cases of serious bleeding, including intracerebral hemorrhage. If the INR measured in these patients are often away from the higher value of the target range, a significant proportion of bleeding were observed for INR between 2 and 3. The study captures the components of the nutritional status of patients on oral anticoagulants, including any micronutrient deficiencies, to determine whether nutritional status is an independent risk factor for bleeding
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 4, 2012
CompletedFirst Posted
Study publicly available on registry
December 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedDecember 6, 2012
December 1, 2012
1.4 years
December 4, 2012
December 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Denutrition diagnosis
at day 1
Secondary Outcomes (9)
Zinc blood level
at day 1
Cupper blood level
at day 1
vitamin C blood level
at day 1
vitamin B1 blood level
at day 1
PINI (pronostic inflammatory and nutritional index)
at day 1
- +4 more secondary outcomes
Study Arms (2)
controls
Patient under anti-vitamin K with no haemorrhagic manifestations admitted for another reason to Emergency Adults
kaskadil
Patient under anti-vitamin K with a serious bleeding event that required treatment in the emergency Adults. Is considered serious accident requiring the use of a reversion by PPSB (Kaskadil ®).
Eligibility Criteria
Be included in this study patients under anti-vitamin K supported or followed the emergency department Adults.
You may qualify if:
- Patients, male or female, aged over 18, under oral anticoagulant therapy with antivitamins K.
- INR greater than 1.5, in the therapeutic range or overdose
- Case-control study: patients under oral anticoagulant with severe hemorrhagic accident compared with patients without hemorrhagic accident. Cases will be matched to controls based on age, sex, and the value of INR :
- Case:
- Patients victims of serious hemorrhagic accident on VKAs, supported emergency Adults.
- Will be considered severe hemorrhagic stroke, accidents requiring the use of a reversion by PPSB (Kaskadil ®)
- Control :
- Patients on VKAs supported the Emergency Adults for a reason other than bleeding.
You may not qualify if:
- underage patients
- Patients who have not read or understood nor signed the consent form or refusal of the reference person.
- pregnant women
- Patients with a pacemaker and / or implantable defibrillator
- Patients with mechanical valve
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
Related Publications (1)
Moustafa F, Dopeux L, Mulliez A, Boirie Y, Morand C, Gentes E, Farigon N, Richard D, Lebreton A, Teissandier D, Dutheil F, Schmidt J. Severe undernutrition increases bleeding risk on vitamin-K antagonists. Clin Nutr. 2021 Apr;40(4):2237-2243. doi: 10.1016/j.clnu.2020.10.002. Epub 2020 Oct 9.
PMID: 33077273DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2012
First Posted
December 6, 2012
Study Start
August 1, 2012
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
December 6, 2012
Record last verified: 2012-12